---
title: "300003.SZ (300003.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300003.SZ/news.md"
symbol: "300003.SZ"
name: "300003.SZ"
parent: "https://longbridge.com/en/quote/300003.SZ.md"
datetime: "2026-05-21T00:39:15.698Z"
locales:
  - [en](https://longbridge.com/en/quote/300003.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300003.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300003.SZ/news.md)
---

# 300003.SZ (300003.SZ) — Related News

### [The second round of centralized procurement for coronary stents has opened for bidding in Tianjin](https://longbridge.com/en/news/287044855.md)
*2026-05-20T10:01:50.000Z*
> On May 20th, the second round of centralized procurement for coronary stents organized by the state opened bidding in Ti

### [Farewell to the transition period! Lepu Medical officially enters the "Post-85 Generation Second-Generation Management Era"](https://longbridge.com/en/news/286658586.md)
*2026-05-17T02:18:38.000Z*
> Lepu Medical completed the re-election of its seventh board of directors on May 13, with founder Pu Zhongjie continuing 

### [The sixth batch of national procurement for consumables will be intensively implemented in May](https://longbridge.com/en/news/285501988.md)
*2026-05-07T07:20:14.000Z*
> The sixth batch of national organized centralized procurement of high-value medical consumables has entered the implemen

### [Lepu Medical: The radiofrequency skin treatment device "Sailoti" has obtained NMPA registration approval](https://longbridge.com/en/news/284360307.md)
*2026-04-28T10:15:00.000Z*
> Lepu Medical's Sichuan Xingtai Pule Medical Technology Co., Ltd. has developed the radiofrequency skin treatment device 

### [Master Zheng's review sharing: Net profit surged by 300%, behind it, is the brain-computer interface a gimmick or real gold?](https://longbridge.com/en/news/284101520.md)
*2026-04-26T05:46:06.000Z*
> Lepu Medical's 2025 annual report shows a year-on-year net profit surge of 289.57%, reaching 962 million. Despite a 9.68

### [Lepu Medical: DBS is currently in the early stages of commercialization](https://longbridge.com/en/news/283788957.md)
*2026-04-23T08:06:00.000Z*
> On April 23rd, Lepu Medical stated on the interactive platform that DBS is currently in the early stages of commercializ

### [Lepu Medical: 2026 is the year when the company's centralized procurement impact will be fully cleared](https://longbridge.com/en/news/283743190.md)
*2026-04-23T01:00:53.000Z*
> Lepu Medical stated at the earnings briefing that 2026 will be the year when the impact of centralized procurement on th

### [Lepu Medical: The interventional multi-channel brain-machine interface product has completed animal experiments and entered the human ITT clinical research stage](https://longbridge.com/en/news/283741258.md)
*2026-04-23T00:39:14.000Z*
> Lepu Medical announced at the performance briefing that the company has achieved a key technological breakthrough in the

### [Lepu Medical: Net profit of 247 million yuan in the first quarter, a year-on-year decline of 34.80%](https://longbridge.com/en/news/283672745.md)
*2026-04-22T13:08:22.000Z*
> Lepu Medical announced that in the first quarter of 2026, it achieved operating revenue of 1.672 billion yuan, a year-on

### [Lepu Medical: Subsidiary plans to acquire Beta Ning® product rights for 450 million yuan](https://longbridge.com/en/news/282690426.md)
*2026-04-14T12:23:17.000Z*
> Lepu Medical announced that its subsidiary Lepu Pharmaceutical has signed an agreement with Baotai to acquire the rights